10 research outputs found

    Índice de estresse hídrico da cultura do feijoeiro irrigado.

    Get PDF
    A determinacao das necessidades hidricas de culturas, em seus diferentes estadios de desenvolvimento, e uma etapa importante para o manejo de irrigacao. Entre os metodos usualmente utilizados, destacam-se o metodo gravimetrico, medidas do potencial de agua na folha, tensiometros e climatologicos. A utilizacao de tecnicas de sensoriamento remoto apresenta-se como uma alternativa importante por permitir a deteccao do status de agua da planta, em funcao da emitancia radiante da superficie da cultura. Dentre os equipamentos usados destaca-se o termometro a infravermelho por sua praticidade de uso. Neste estudo utilizou-se a termometria infravermelha, associada ao balanco de energia para obtencao de um indice de estresse hidrico da cultura (IEHC) do feijoeiro (Phaseolus vulgaris L.) que possibilitasse ao irrigante saber em tempo real, nos diferentes estadios de desenvolvimento da cultura, quando irrigar. Os valores do IEHC variaram de -0,06 a 0,053; -0,041 a 0,221 e -0,038 a 0,108, respectivamente, para os niveis de tensao de umidade do solo de 0,04; 0,06 e 0,08 MPa. Embora os indices obtidos nao tenham apresentado diferencas acentuadas entre os tratamentos, os resultados evidenciam o potencial do metodo para realizacao do manejo de irrigacao

    Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

    Get PDF
    BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to <90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], >300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of <15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P<0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P<0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years

    Desempenho de cultivares de minitomate em condições de verão do Submédio do Vale do São Francisco.

    No full text
    C om o objetivo de avaliar o desempenho de cultivares de minitomate com hábito de crescimento determinado, realizou-se um ensaio no Campo Experimental de Bebedouro, Petrolina, PE, entre os meses de agosto e dezembro de 2012. Foram testadas seis cultivares (Kada; Tanzimech; E5663; F1170; E12-75 e Abirú), no delineamento de blocos casualizados, com quatro repetições. Avaliaram-se a produtividade total e comercial, massa total de frutos por planta e número de frutos por hectare. A cultivar E5663 se destacou com maior produtividade total (40,3 t ha-1) e comercial (39,9 t ha-1) de frutos. A massa fresca de fruto por planta apresentou variações entre 1,41 e 3,22 kg, sendo o melhor resultado obtido pela cultivar E5663, com 3,22 kg de frutos.planta-1. Em relação ao número total de frutos por planta, houve uma variação de 96,37 a 315,413, com melhor desempenho para as cultivares E5663 (315,41 frutos) e Kada (302,04 frutos). Pelos resultados alcançados, a cultivar E5663 apresentou o melhor desempenho em termos de produtividade, produção por planta e maior número de frutos por planta. Por isso é a mais indicada para o cultivo no Submédio do Vale do São Francisco

    Rivaroxaban with or without aspirin in stable cardiovascular disease

    No full text
    BACKGROUND: We evaluated whether rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone for secondary cardiovascular prevention. METHODS: In this double-blind trial, we randomly assigned 27,395 participants with stable atherosclerotic vascular disease to receive rivaroxaban (2.5 mg twice daily) plus aspirin (100 mg once daily), rivaroxaban (5 mg twice daily), or aspirin (100 mg once daily). The primary outcome was a composite of cardiovascular death, stroke, or myocardial infarction. The study was stopped for superiority of the rivaroxaban-plus-aspirin group after a mean follow-up of 23 months. RESULTS: The primary outcome occurred in fewer patients in the rivaroxaban-plus-aspirin group than in the aspirin-alone group (379 patients [4.1%] vs. 496 patients [5.4%]; hazard ratio, 0.76; 95% confidence interval [CI], 0.66 to 0.86; P<0.001; z=−4.126), but major bleeding events occurred in more patients in the rivaroxaban-plus-aspirin group (288 patients [3.1%] vs. 170 patients [1.9%]; hazard ratio, 1.70; 95% CI, 1.40 to 2.05; P<0.001). There was no significant difference in intracranial or fatal bleeding between these two groups. There were 313 deaths (3.4%) in the rivaroxaban-plus-aspirin group as compared with 378 (4.1%) in the aspirin-alone group (hazard ratio, 0.82; 95% CI, 0.71 to 0.96; P=0.01; threshold P value for significance, 0.0025). The primary outcome did not occur in significantly fewer patients in the rivaroxaban-alone group than in the aspirin-alone group, but major bleeding events occurred in more patients in the rivaroxaban-alone group. CONCLUSIONS: Among patients with stable atherosclerotic vascular disease, those assigned to rivaroxaban (2.5 mg twice daily) plus aspirin had better cardiovascular outcomes and more major bleeding events than those assigned to aspirin alone. Rivaroxaban (5 mg twice daily) alone did not result in better cardiovascular outcomes than aspirin alone and resulted in more major bleeding events

    Palm species richness, latitudinal gradients, sampling effort, and deforestation in the Amazon region

    No full text
    ABSTRACT Palms are most diverse in warm and humid regions near the equator. Though palms remain relatively well conserved, they are under increasing pressure from deforestation. Here, we analyze patterns of palm species richness relative to latitudinal gradient, sampling effort, and deforestation in the Amazon, and compare patterns of richness and floristic similarity among Amazonian sub-regions. We built a database of 17,310 records for 177 species. The areas with the greatest richness were in the western, central and northeastern Amazon, principally at latitudes 0-5ºS. Species richness and the number of records were highly correlated (R2=0.76, P2000 km2) were found in the southern and eastern Amazon of Brazil, which coincide with low richness and gaps in records. Similarity analyzes resulted in two groups of sub-regions: the first included the Amazon s.s., the Andes and the Guiana, while the second included the Plateau and Gurupi. We conclude that the highest species richness is at low latitudes, and observed richness is affected by sampling effort and is vulnerable to deforestation. Therefore, areas with low species richness, especially areas with data deficiency, need to be further studied for a better understanding of their patterns of diversity and richness

    Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis

    No full text
    BACKGROUND AND PURPOSE: Chronic kidney disease with reduced estimated glomerular filtration rate or elevated albuminuria increases risk for ischemic and hemorrhagic stroke. This study assessed the effects of sodium glucose cotransporter 2 inhibitors (SGLT2i) on stroke and atrial fibrillation/flutter (AF/AFL) from CREDENCE (Canagliflozin and Renal Events in Diabetes With Established Nephropathy Clinical Evaluation) and a meta-analysis of large cardiovascular outcome trials (CVOTs) of SGLT2i in type 2 diabetes mellitus.METHODS: CREDENCE randomized 4401 participants with type 2 diabetes mellitus and chronic kidney disease to canagliflozin or placebo. Post hoc, we estimated effects on fatal or nonfatal stroke, stroke subtypes, and intermediate markers of stroke risk including AF/AFL. Stroke and AF/AFL data from 3 other completed large CVOTs and CREDENCE were pooled using random-effects meta-analysis.RESULTS: In CREDENCE, 142 participants experienced a stroke during follow-up (10.9/1000 patient-years with canagliflozin, 14.2/1000 patient-years with placebo; hazard ratio [HR], 0.77 [95% CI, 0.55-1.08]). Effects by stroke subtypes were: ischemic (HR, 0.88 [95% CI, 0.61-1.28]; n=111), hemorrhagic (HR, 0.50 [95% CI, 0.19-1.32]; n=18), and undetermined (HR, 0.54 [95% CI, 0.20-1.46]; n=17). There was no clear effect on AF/AFL (HR, 0.76 [95% CI, 0.53-1.10]; n=115). The overall effects in the 4 CVOTs combined were: total stroke (HRpooled, 0.96 [95% CI, 0.82-1.12]), ischemic stroke (HRpooled, 1.01 [95% CI, 0.89-1.14]), hemorrhagic stroke (HRpooled, 0.50 [95% CI, 0.30-0.83]), undetermined stroke (HRpooled, 0.86 [95% CI, 0.49-1.51]), and AF/AFL (HRpooled, 0.81 [95% CI, 0.71-0.93]). There was evidence that SGLT2i effects on total stroke varied by baseline estimated glomerular filtration rate (P=0.01), with protection in the lowest estimated glomerular filtration rate (&lt;45 mL/min/1.73 m2]) subgroup (HRpooled, 0.50 [95% CI, 0.31-0.79]).CONCLUSIONS: Although we found no clear effect of SGLT2i on total stroke in CREDENCE or across trials combined, there was some evidence of benefit in preventing hemorrhagic stroke and AF/AFL, as well as total stroke for those with lowest estimated glomerular filtration rate. Future research should focus on confirming these data and exploring potential mechanisms. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02065791
    corecore